Paradigm Biocapital Advisors LP - Dec 31, 2024 Form SCHEDULE 13G/A Schedule Report for Janux Therapeutics, Inc. (JANX)

Filing Manager
Paradigm Biocapital Advisors LP
Reporting Manager
Paradigm BioCapital Advisors LP
Security
Janux Therapeutics, Inc. Common Stock, $0.001 par value per share
Symbol
JANX
Shares outstanding
58.6M shares
Disclosed Ownership
3.52M shares
Ownership
6%
Form type
SCHEDULE 13G/A
Date filed
2/14/2025, 04:41 PM
Date of event
Dec 31, 2024
SEC
View on sec.gov

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Paradigm BioCapital Advisors LP 6% 3.52M 3.52M 0 /s/ David K. Kim David K. Kim / Authorized Signatory
Paradigm BioCapital Advisors GP LLC 6% 3.52M 3.52M 0 /s/ David K. Kim David K. Kim / Authorized Signatory
Senai Asefaw, M.D. 6% 3.52M 3.52M 0 /s/ Senai Asefaw, M.D. N/A
Paradigm BioCapital International Fund Ltd. 5.2% 3.03M 3.03M 0 /s/ David K. Kim David K. Kim / Authorized Signatory